StonvexLoading…
StonvexStonvexStonvexCore line items from BDTX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2020 2020-12-31 | Annual 2020 2020-09-30 | Annual 2020 2020-06-30 | Annual 2020 2020-03-31 |
|---|---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
Operating Income | $-69.57M | $-46.39M | $-27.91M | $-12.88M |
Net Income | $-67.25M | $-44.63M | $-14.57M | $-12.14M |
EPS (Diluted) | $-2.05 | $-1.42 | $-0.92 | $-0.51 |
Total Assets | $329.67M | $346.44M | $349.45M | $362.80M |
Total Liabilities | $21.91M | $19.09M | $6.33M | $7.54M |
Cash & Equivalents | $34.60M | $56.20M | $63.98M | $357.19M |
Free Cash Flow OCF − CapEx | $-52.29M | $-36.41M | $-24.91M | $-11.32M |
Shares Outstanding | 36.08M | 35.96M | 35.91M | 35.91M |